These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2141372

  • 1. Interrelationships among the renin-angiotensin system, sympathetic nervous system and atrial natriuretic peptide in end-stage renal failure.
    Nakajima S, Suzuki H, Kageyama Y, Ogata Y, Saruta T.
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):305-11. PubMed ID: 2141372
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Relationship between vasoactive substances and changes in blood pressure during hemodialysis].
    Takahashi M.
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):549-57. PubMed ID: 7474507
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides.
    Mallamaci F, Cutrupi S, Pizzini P, Tripepi G, Zoccali C.
    J Nephrol; 2005 Oct; 18(6):727-32. PubMed ID: 16358231
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of hemodialysis on the plasma levels of the atrial natriuretic factor in chronic renal failure.
    Larochelle P, Béroniade V, Gutkowska J, Cusson JR, Lécrivain A, du Souich P, Cantin M, Genest J.
    Clin Invest Med; 1987 Jul; 10(4):350-4. PubMed ID: 2958203
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aerobic fitness: I. Response of volume regulating hormones to head-down tilt.
    Shi X, Squires WG, Williamson JW, Crandall CG, Chen JJ, Krock LP, Raven PB.
    Med Sci Sports Exerc; 1992 Sep; 24(9):991-8. PubMed ID: 1406200
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Altered regulation of renal interstitial hydrostatic pressure and the renal renin-angiotensin system in the absence of atrial natriuretic peptide.
    O'Tierney PF, Komolova M, Tse MY, Adams MA, Pang SC.
    J Hypertens; 2008 Feb; 26(2):303-11. PubMed ID: 18192845
    [Abstract] [Full Text] [Related]

  • 16. The kidney and essential hypertension.
    Balsano F.
    Ann Ital Med Int; 1991 Feb; 6(1 Pt 2):93-106. PubMed ID: 1835873
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
    Elias AN, Vaziri ND, Pandian MR, Kaupke J.
    Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
    [Abstract] [Full Text] [Related]

  • 19. Activity of the renin-angiotensin-aldosterone (RAA) and secretion of the atrial natriuretic peptide (ANP) in patients with chronic renal failure.
    Irzyniec T, Kokot F, Grzeszczak W.
    Mater Med Pol; 1991 Mar; 23(2):125-9. PubMed ID: 1842598
    [Abstract] [Full Text] [Related]

  • 20. The rate of increase in hematocrit, humoral vasoactive substances and blood pressure changes in hemodialysis patients treated with recombinant human erythropoietin or blood transfusion.
    Ono K, Hisasue Y.
    Clin Nephrol; 1992 Jan; 37(1):23-7. PubMed ID: 1531789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.